Results 11 to 20 of about 94,624 (285)

Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit” [PDF]

International Brazilian Journal of Urology, 2017
Background Prostate-specific antigen densities have limited success in diagnosing prostate cancer. We emphasise the importance of the peripheral zone when considered with its cellular constituents, the “prostatocrit”. Objective Using zonal volumes and
Simon Robinson, Marc Laniado, Bruce Montgomery   +2 more
doaj   +5 more sources

The prostate health index (PHI) density: Are there advantages over PHI or over the prostate-specific antigen density?

Clinica Chimica Acta, 2021
Background and aims: Overdiagnosis of prostate cancer (PCa) should be minimized. We wanted to evaluate the diagnostic performance of the prostate health index density (PHID) and compare it with that of the prostate health index (PHI) alone and of the ...
Manuel M Garrido, Ruy M Ribeiro, João Tiago Guimarães   +2 more
exaly   +2 more sources

The ability of free to total prostate-specific antigen and prostate-specific antigen density to detect clinically significant prostate cancer in men undergoing transperineal template biopsy

Journal of Clinical Urology, 2017
The ability of free to total prostate-specific antigen and prostate-specific antigen density to detect clinically significant prostate cancer in men undergoing transperineal template biopsy Show all authors Surayne V Segaran, Amr M Emara, Tharani Mahesan,
Amr Emara, Joshua Silverman, Hashim U Ahmed   +2 more
exaly   +2 more sources

Automating prostate volume acquisition using abdominal ultrasound scans for prostate-specific antigen density calculations [PDF]

Scientific Reports
Proposed methods for prostate cancer screening are currently prohibitively expensive (due to the high costs of imaging equipment such as magnetic resonance imaging and traditional ultrasound systems), inadequate in their detection rates, require highly ...
Rory Douglas Bennett, Tristan Barrett, Nikita Sushentsev, Nimalan Sanmugalingam, Kang-Lung Lee, Vincent J. Gnanapragasam, Zion Tsz Ho Tse   +6 more
doaj   +2 more sources

Performance characteristics of prostate-specific antigen density and biopsy primary Gleason score to predict biochemical failure in patients with intermediate prostate cancer who underwent radical prostatectomy

Cancer Management and Research, 2019
Chao Peng, Jun Zhang, Jianquan Hou Department of Urology, First Affiliated Hospital of Soochow University, Suzhou 215006, China Background: Prognosis for intermediate-risk prostate cancer (PCa) remains variable; therefore, we aimed to investigate high ...
Peng C, Zhang J, Hou JQ
doaj   +1 more source

Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men

Urology Journal, 2009
<p><strong>Introduction:</strong> The objective of this study was to evaluate the value of serum prostate-specific antigen (PSA) and prostate-specific antigen density (PSAD) in the diagnosis of prostate cancer.</p><p>< ...
Mahyar Ghafoori, Peyman Varedi, Seyed Jalil Hosseini, Mojgan Asgari, Madjid Shakiba   +4 more
doaj   +3 more sources

Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies. [PDF]

Eur Radiol
<jats:title>Abstract</jats:title><jats:sec> <jats:title>Objectives</jats:title> <jats:p>To develop and test zone-specific prostate-specific antigen density (sPSAD) combined with PI-RADS ...
Hamm CA, Baumgärtner GL, Padhani AR, Froböse KP, Dräger F, Beetz NL, Savic LJ, Posch H, Lenk J, Schallenberg S, Maxeiner A, Cash H, Günzel K, Hamm B, Asbach P, Penzkofer T.   +15 more
europepmc   +2 more sources

Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? [PDF]

European Urology Focus, 2023
Pellegrino F, Tin AL, Martini A, Vertosick EA, Porwal SP, Stabile A, Gandaglia G, Eastham JA, Briganti A, Montorsi F, Vickers AJ.   +10 more
exaly   +2 more sources

Usefulness of prostate specific antigen density in detecting prostate carcinoma: A hospital-based study in patients with prostate biopsies

Journal of Pathology of Nepal, 2022
Background: Prostate-specific antigen density has been suggested to enhance the diagnostic efficacy of serum prostate-specific antigen alone in detecting prostate cancer, thereby reducing unnecessary biopsies and associated morbidities.
Reshmi Shrestha, Shova Kunwar, Suman Gurung, Anjana Nuri Pokharel   +3 more
doaj   +1 more source

Does prostate-specific antigen density alter decision making on biopsy?

European Urology, 1996
The ability of prostate-specific antigen density (PSAD) to predict prostate cancer in biopsy specimens is evaluated in patients with benign digital rectal examination (DRE) and prostate-specific antigen (PSA) between 4.0 and 10.0 ng/ml.
van Andel, G., Kurth, K. H., de Reijke, T. M., Vleeming, R., de Craen, A. J.   +4 more
core   +4 more sources